- Home
- NRIX vs GSL Comparison
NRIX vs GSL Comparison
Compare NRIX & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | GSL |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | Greece |
| Employees | N/A | 11 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRIX | GSL |
|---|---|---|
| Price | $14.80 | $36.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $30.58 | ★ $43.50 |
| AVG Volume (30 Days) | ★ 891.7K | 397.7K |
| Earning Date | 04-10-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 6.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.32 | N/A |
| P/E Ratio | ★ N/A | $3.49 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.18 | $17.73 |
| 52 Week High | $22.50 | $41.40 |
Technical Indicators
Market Signals| Indicator | NRIX | GSL |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 40.85 |
| Support Level | $11.34 | $35.03 |
| Resistance Level | $16.47 | $37.06 |
| Average True Range (ATR) | 0.85 | 0.97 |
| MACD | 0.05 | -0.19 |
| Stochastic Oscillator | 36.53 | 2.84 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.